|
|
The older the better: The characteristic of localized prostate cancer in Chinese men |
Haifeng Wang, Xu Gao, Ziyu Fang, Xin Lu, Yan Wang, Chunfei Ma, Zhenkai Shi, Bo Yang, Shancheng Ren, Chuanliang Xu, Yinghao Sun
|
Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China |
|
|
Abstract Objective: To assess the clinicopathological features and overall survival between two groups of Chinese patients older or younger than 70 years after retropubic radical prostatectomy. Methods: From January 2001 to February 2010, 390 patients receive dretropubic radical prostatectomy. After excluding 89 patients with adjuvant or neoadjuvant hormonal therapy or radiotherapy, a total of 301 patients were included in this study. We arbitrarily divided these patients into younger age group (<70 years, 140 cases, 46.5%) and older age group (70 years, 161 cases, 53.5%). The differences in serum prostate specific antigen (PSA), Gleason score, clinical tumor stage, and biochemical-free survival were analyzed between the two groups. Results: There were not significant differences between the two groups in high Gleason score rate and clinical tumor stage. However, older patients had significantly lower biochemical recurrence rate than those of younger patients, and had significantly higher PSA levels. Multivariate analysis showed that older age, PSA level and clinical tumor stage were significantly associated with biochemical recurrence free survival. Conclusion: In Chinese men, older age (70 years) is associated with better outcome. If the physical condition permits, older age alone should not exclude patients from radical prostatectomy.
|
Received: 25 June 2015
Published: 18 September 2015
|
Corresponding Authors:
Yinghao Sun
E-mail: sunyh@medmail.com.cn
|
|
|
[1] |
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-10.
|
[2] |
Yu H, Harris RE, Gao YT, Gao R, Wynder EL. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol 1991;20:76-61.
|
[3] |
Ren S, Peng Z, Mao JH, Yu Y, Yin C, Gao X, et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res 2012; 22:806-61.
|
[4] |
Fowler Jr FJ, McNaughton CM, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000;283:3217-72.
|
[5] |
Centers for Disease Control and Prevention (CDC). Trends in agingeUnited States and worldwide. MMWR Morb Mortal Wkly Rep 2003;52:101-1.106.
|
[6] |
Minino AM, Smith BL. Deaths:preliminary data for 2000. Natl Vital Stat Rep 2001;49:1-10.
|
[7] |
Richstone L, Bianco FJ, Shah HH, Kattan MW, Eastham JA, Scardino PT, et al. Radical prostatectomy in men aged > or =70 years:effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram. BJU Int 2008;101:541-1.
|
[8] |
Siddiqui SA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Myers RP, et al. Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer. J Urol 2006;175:952-2.
|
[9] |
Greco KA, Meeks JJ, Wu S, Nadler RB. Robot-assisted radical prostatectomy in men aged > or =70 years. BJU Int 2009;104:1492-2.
|
[10] |
Pfitzenmaier J, Pahernik S, Buse S, Haferkamp A, Djakovic N, Hohenfellner M. Survival in prostate cancer patients > or =70 years after radical prostatectomy and comparison to younger patients. World J Urol 2009;27:637-72.
|
[11] |
Brassell SA, Rice KR, Parker PM, Chen Y, Farrell JS, Cullen J, et al. Prostate cancer in men 70 years old or older, indolent or aggressive:clinicopathological analysis and outcomes. J Urol 2011;185:132-2.
|
[12] |
Xu DD, Sun SD, Wang F, Sun L, Stackhouse D, Polascik T, et al. Effect of age and pathologic Gleason score on PSA recurrence:analysis of 2911 patients undergoing radical prostatectomy. Urology 2009;74:654-4.
|
[13] |
Kim JK, Cho SY, Jeong CW, Lee SB, Ku JH, Hong SK, et al. Patients aged more than 70 had higher risk of locally advanced prostate cancers and biochemical recurrence in Korea. BJU Int 2012;110:505-5.
|
[14] |
Masuda H, Fukushima H, Kawakami S, Numao N, Fujii Y, Saito K, et al. Impact of advanced age on biochemical recurrence after radical prostatectomy in Japanese men according to pathological stage. Jpn J Clin Oncol 2013;43:410-0.
|
[1] |
S. Sfanos Karen,Yegnasubramanian Srinivasan,G. Nelson William,L. Lotan Tamara,Kulac Ibrahim,L. Hicks Jessica,Zheng Qizhi,J. Bieberich Charles,C. Haffner Michael,M. De Marzo Angelo. If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease[J]. Asian Journal of Urology, 2019, 6(1): 10-25. |
[2] |
Dong Liang,C. Zieren Richard,Xue Wei,M. de Reijke Theo,J. Pienta Kenneth. Metastatic prostate cancer remains incurable, why?[J]. Asian Journal of Urology, 2019, 6(1): 26-41. |
[3] |
M. Armstrong Cameron,C. Gao Allen. Current strategies for targeting the activity of androgen receptor variants[J]. Asian Journal of Urology, 2019, 6(1): 42-49. |
[4] |
B. Isaacs William,Xu Jianfeng. Current progress and questions in germline genetics of prostate cancer[J]. Asian Journal of Urology, 2019, 6(1): 3-9. |
[5] |
Zhou Liqun,Yang Kaiwei,Li Xuesong,Ding Yi,Mu Dawei,Li Hanzhong,Yan Yong,Li Jinyi,Wang Dongwen,Li Wei,Cong Yulong,Gao Jiangping,Ma Kewei,Xiao Yajun,Zhang Sheng,Jiang Hongyi,Hu Weilie,Wei Qiang,Jin Xunbo,Guan Zhichen,Liu Qingyong,Xu Danfeng,Gao Xin,Jiang Yongguang,Gan Weimin,Sun Guang,Wang Qing,Liu Yanhui,Hou Jianquan,Xie Liping,Song Xishuang,Jin Fengshuo,Feng Jiafu,Cai Ming,Liang Zhaozhao,Zhang Jie,Ye Dingwei,Qi Lin,Ma Lulin,Shou Jianzhong,Dai Yuping,Shao Jianyong,Tian Ye,Hong Shizhe,Xu Tao,Kong Chuize,Kang Zefeng,Liu Yuexin,Qu Xun,Shi Benkang,Zheng Shaobin,Lin Yi,Xia Shujie,Wei Dong,Wu Jianbo,Fu Weiling,Wang Zhiping,Liang Jianbo. Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population☆(☆ Hospitals 1 and 3w53 were all in the study group of Fluorescence in situ hybridization in prenatal genetic diseases and cancer detection in clinical research of Chinese population.)[J]. Asian Journal of Urology, 2019, 6(1): 114-121. |
[6] |
Etheridge Tyler,Damodaran Shivashankar,Schultz Adam,A. Richards Kyle,Gawdzik Joseph,Yang Bing,Cryns Vincent,F. Jarrard David. Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier[J]. Asian Journal of Urology, 2019, 6(1): 57-64. |
[7] |
Chia-Yi Chu Gina,W.K. Chung Leland,Gururajan Murali,Hsieh Chia-Ling,Josson Sajni,Nandana Srinivas,Sung Shian-Ying,Wang Ruoxiang,Boyang Wu Jason,E. Zhau Haiyen. Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics[J]. Asian Journal of Urology, 2019, 6(1): 65-81. |
[8] |
Dicken Haley,J. Hensley Patrick,Kyprianou Natasha. Prostate tumor neuroendocrine differentiation via EMT: The road less traveled[J]. Asian Journal of Urology, 2019, 6(1): 82-90. |
[9] |
Xu Lingfan,Chen Junyi,Liu Weipeng,Liang Chaozhao,Hu Hailiang,Huang Jiaoti. Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer[J]. Asian Journal of Urology, 2019, 6(1): 91-98. |
[10] |
A. Wollin Daniel,G. Kaplan Adam,M. Preminger Glenn,Manuel Ferraro Pietro,Nouvenne Antonio,Tasca Andrea,Croppi Emanuele,Gambaro Giovanni,P. Heilberg Ita. Defining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers[J]. Asian Journal of Urology, 2018, 5(4): 235-242. |
[11] |
Sorokin Igor,S. Pearle Margaret. Medical therapy for nephrolithiasis: State of the art[J]. Asian Journal of Urology, 2018, 5(4): 243-255. |
[12] |
Chen Kenneth,Jack Tay Kae,Mee Law Yan,Aydin Hakan,Ho Henry,Cheng Christopher,Shyi Peng Yuen John. Outcomes of combination MRI-targeted and transperineal template biopsy in restaging low-risk prostate cancer for active surveillance[J]. Asian Journal of Urology, 2018, 5(3): 184-193. |
[13] |
Chen Shulian,Gao Rang,Li Hong,Wang Kunjie. Management of acquired rectourethral fistulas in adults[J]. Asian Journal of Urology, 2018, 5(3): 149-154. |
[14] |
Chen Kenneth,Sim Allen,Kan Alex Ford. The effect of adjunct caudal block on postoperative analgesia in robot-assisted laparoscopic radical prostatectomy: A prospective randomized controlled, single blinded pilot study in a tertiary centre[J]. Asian Journal of Urology, 2018, 5(2): 122-126. |
[15] |
Su Jiarui,Jonathan Aslim Edwin,Aydin Hakan,HoonTan Puay,Sun SienHo Henry. A rare case of isolated castrate resistant bilateral testicular metastases in advanced prostate cancer[J]. Asian Journal of Urology, 2018, 5(2): 127-130. |
|
|
|
|